All In Biotech

Drug Trial Radar · NCT03768388

Levoketoconazole Food Effect Study in Healthy Subjects

A Phase I Randomized, Open-Label, Two-Period, Two-Sequence Crossover Study to Evaluate the Effect of Food on the Pharmacokinetics of Levoketoconazole in Healthy Subjects

Last checked: Nov 20, 2026Latest source record: Feb 4, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

22

Actual

Start

Nov 30, 2018

Primary completion

Dec 24, 2018

Study completion Dec 24, 2018

Sponsor

Lead sponsor
Cortendo ABIndustry
Sponsor type
Industry
First posted
Dec 7, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Other
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a phase I, randomized, open-label, single-dose, two-period, two-sequence crossover study in healthy male and female subjects to evaluate the effect of food on the PK of levoketoconazole.

Conditions

  • Healthy Subjects

Interventions

  • levoketoconazoleDrug

    food effect

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Maximum observed plasma concentration (Cmax) of levoketoconazoleTime frame: 24 hours
  2. Time to maximum concentration (Tmax) of levoketoconazoleTime frame: 24 hours
  3. Apparent Terminal Elimination Phase Rate Constant (λz) of levoketoconazoleTime frame: 24 hours
  4. Terminal phase half-life (t 1/2) of levoketoconazoleTime frame: 24 hours
  5. Area under the plasma concentration-time curve (AUC) of levoketoconazoleTime frame: 24 hours

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Clinical Pharmacology of Miami, LLC

    Miami, Florida

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.